← Leaderboards
John R. Subjeck
Roswell Park Cancer Institute Corp
$12,071,773
Attributed
$12,485,271
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$12,485,271 · 4
By mechanism
P01$6,848,170 · 1
R01$5,543,397 · 2
R41$93,704 · 1
Top collaborators
- Xiang-Yang Wang3 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Xiang-Yang Wang$11,998,946
- Elizabeth Repasky$12,725,917
- Walter J Storkus$19,974,413
- John David Carpten$9,472,293
- Sandra O Gollnick$8,125,802
Others in their field
Top investigators on “Molecular Chaperones”
- Scott J Hultgren · Washington University$24,111,975
- Judith Frydman · Stanford University$23,842,034
- Wah Chiu · Baylor College Of Medicine$22,055,847
- Randal J. Kaufman · Indiana University Indianapolis$21,677,694
- Richard I. Morimoto · Northwestern University$18,534,805
- William Tobey Wickner · Dartmouth College$17,981,123
Research focus
Molecular ChaperonesHeat Shock ProteinsFutureVaccinesTumorCancer TherapyImmune ResponseHeat-Shock ResponseReceptorAntigensComplexImmuneTumor ImmunityDesignDendritic CellsProteinsStress ProteinTumor AntigensClinical TrialsMolecularMouse ModelAntigen-Presenting CellsImmunityImmunotherapy
Grant awards (22)
Large heat shock proteins and their role in cancer therapy$327,797
R01 · FY2017 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$155,000
R01 · FY2017 · CA · contact PI
Large heat shock proteins and their role in cancer therapy$344,200
R01 · FY2016 · CA · contact PI
HSP 110 and its role in cancer therapy$375,693
R01 · FY2012 · CA · contact PI
HSP 110 and its role in cancer therapy$370,504
R01 · FY2011 · CA · contact PI
HSP 110 and its role in cancer therapy$376,769
R01 · FY2010 · CA · contact PI
HSP 110 and its role in cancer therapy$371,726
R01 · FY2009 · CA · contact PI
HSP 110 and its role in cancer therapy$366,830
R01 · FY2008 · CA · contact PI
Heat Shock Protein and Thermal Therapy of Cancer$1,396,380
P01 · FY2007 · CA · contact PI
HSP 110 Family and its Role in Cancer Therapy$357,508
R01 · FY2007 · CA · contact PI
Heat Shock Protein and Thermal Therapy of Cancer$1,396,711
P01 · FY2006 · CA · contact PI
HSP 110 Family and its Role in Cancer Therapy$368,185
R01 · FY2006 · CA · contact PI
Heat Shock Protein and Thermal Therapy of Cancer$1,389,197
P01 · FY2005 · CA
HSP 110 Family and its Role in Cancer Therapy$377,046
R01 · FY2005 · CA
Heat Shock Protein and Thermal Therapy of Cancer$1,349,240
P01 · FY2004 · CA
HSP 110 Family and its Role in Cancer Therapy$377,046
R01 · FY2004 · CA
Heat Shock Protein and Thermal Therapy of Cancer$1,316,642
P01 · FY2003 · CA
HSP 110 Family and its Role in Cancer Therapy$377,046
R01 · FY2003 · CA
HSP 110 FAMILY AND ITS ROLES IN THERMOTOLERANCE$342,504
R01 · FY2002 · GM
HSP110-lung tumor antigen complex as a cancer vaccine$93,704
R41 · FY2002 · CA
HSP 110 FAMILY AND ITS ROLES IN THERMOTOLERANCE$332,586
R01 · FY2001 · GM
HSP 110 FAMILY AND ITS ROLES IN THERMOTOLERANCE$322,957
R01 · FY2000 · GM